This article is sponsored by EndoChoice.The most revolutionary trends in gastrointestinal disease imaging, diagnostics and treatment cover the Institute for Healthcare Improvement’s triple aim: ...
Gastrointestinal endoscopy player EndoChoice has filed with the SEC for a big IPO that's long been rumored to raise up to $115 million. Med tech players have been facing a mixed bag on Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback